Skip to content
Congress·In Committee·9 months ago

Senate Bill Would Expand Medicare Obesity Coverage to More Providers, Add Weight-Loss Drug Benefits

Also known as: Treat and Reduce Obesity Act of 2025

Legislative Progress

✓ Filed
Review
Senate
House
President

Impacts

Positive Impacts(3)
Medicare
Helps
Chronic Illness
Helps
Retiree
Helps

Key Points

  • Medicare could let more providers deliver obesity counseling, not just primary care doctors, as long as care is coordinated with a referring clinician.
  • Eligible providers could include nurse practitioners, physician assistants, clinical psychologists, and registered dietitians, plus approved community lifestyle programs.
  • Medicare drug plans could be required to cover obesity medications when used to treat obesity, and for some overweight people with related health problems.
  • The prescription drug coverage change would start for plan years beginning 2 years after the law is enacted, so it would not be immediate.
  • The Health and Human Services Department would have to report to Congress within 1 year of enactment, and then every 2 years, on how implementation is going.
HealthcareMedicare MedicaidPrescription Drugs

Milestones

2 milestones2 actions
Jun 5, 2025Senate

Read twice and referred to the Committee on Finance.

Jun 5, 2025

Introduced in Senate

What Happens Next

Projected impacts based on AI analysis

Soon after enactment

HHS starts planning how to expand who can provide Medicare-covered intensive behavioral therapy for obesity

If the law is enacted, Medicare could begin setting rules so beneficiaries can be referred to dietitians, psychologists, NPs/PAs, or approved community programs for counseling, not just primary care

Related News

3 articles
Managed Healthcare Executive·4 months ago

Will Medicare and Medicaid Cover Obesity Drugs?

Lawmakers have introduced the Treat and Reduce Obesity Act of 2025 to mandate Medicare coverage for FDA-approved obesity medications and visits with specialists. The bill would allow a variety of practitioners, including registered dietitians, to provide intensive behavioral therapy.

C=
MedPage Today·4 months ago

Medicare to Cover Blockbuster Obesity Drugs

President Trump announced a deal to expand Medicare coverage for semaglutide and tirzepatide for weight management. While the administration is using pilot programs, the Treat and Reduce Obesity Act remains the legislative path to permanently codify these benefits and expand counseling access.

C+
Kiplinger·4 months ago

Medicare to Cover Obesity Drugs Under Trump Deal for as Little as $50. What You Need to Know

A landmark deal with pharmaceutical companies will expand Medicare coverage for weight-loss medications starting in mid-2026. This move aligns with goals of the Treat and Reduce Obesity Act, which seeks to modernize Medicare by removing outdated barriers to comprehensive obesity care.

C+

Source Information

Document Type

Congressional Bill

Official Title

Treat and Reduce Obesity Act of 2025

Bill NumberS 1973
Congress119th Congress
ChamberSenate
Latest ActionRead twice and referred to the Committee on Finance.

Sponsor

Cosponsors

(22)
D: 16R: 6

Analysis generated by AI. While we strive for accuracy, this should not be considered legal or professional advice. Always verify information with official government sources.